Research & Projects

ESCMID Panorama

ESCMID Study Group for Genomic and Molecular Diagnostics - ESGMD

News & Activities

Here is the new ESGMD Executive Committee:

  • Jacob Moran Gilad (IL), chairperson
  • John Rossen (NL), secretary
  • Eric Claas (NL), treasurer
  • Colin MacKenzie (DE), board member
  • Marijke Raymaekers (BE), board member
  • Paul Savelkoul (NL), board member
  • Kate Templeton (UK), board member
  • Adrian Egli (CH), board member (candidate)
  • Gilbert Greub (CH), board member (candidate)

 

We thank the entire previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work. On the Executive Committee website, all EC member have their areas of responsibility listed.

The mission & objectives of the group have been updated and the name slightly changed to ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD).

Your new Executive Committee

  • Saturday, 9 April 2016
    8.45 h - 10.45 h (Hall C)
    2-hour Educational Workshop EW003: Diagnosis of intestinal protozoan infections: the best way to go
    11.00 h - 13.00 h (Hall D)
    2-hour Educational Workshop EW014: Plasmids without frontiers: mechanisms related to MDR and implications for epidemiology and infection control
  • Sunday, 10 April 2016
    13.15 h - 14.15 h (Room: G111)
    ESGMD Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
  • Monday, 11 April 2016
    7.45 h - 8.45 h (Hall D)
    Meet-the-Expert Session ME079: How to diagnose and treat infections due to Mycoplasma genitalium and other emerging sexually transmitted pathogens
  • Saturday, 25 April 2015
    08.45 - 10.45 (Hall G)
    ESGMD Educational Workshop EW07: Mycoplasma pneumoniae: epidemiology, diagnosis and treatment. Organized jointly with the Mycoplasma Group (ESGMI).
    11.00 - 13.00 (Hall H)
    ESGMD Educational Workshop EW17: Infection prevention and control measures in Europe 2020. Organized jointly with the Epidemiological Markers Group (ESGEM) and the European Committee on Infection Control (EUCIC).
    16.30 - 18.30 (Hall E)
    ESGMD Symposium SY08: Added value of syndrome-based molecular diagnosis?
  • Sunday, 26 April 2015
    07.45 - 08.45 (Hall L)
    ESGMD Meet-the-Expert Session ME04: How to integrate molecular platforms in the laboratory?
    13.15 - 14.15 (Room 21)
    ESGMD Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
  • Monday, 27 April 2015
    07.45 - 08.45 (Hall M)
    ESGMD Meet-the-Expert Session ME11: What bioinformatics tools do I use for whole-genome sequence (WGS)-based bacterial diagnostics and typing? Organized jointly with the Epidemiological Markers Group (ESGEM).
    09.00 - 11.00 (Hall C)
    ESGMD Symposium SY28: Clinical perspectives of human microbiome research.
    16.00 - 18.00 (Hall C)
    ESGMD Symposium SY40: News from basic science for clinical application in Clostridium difficile infections. Organized jointly with the Clostridium difficile Group (ESGCD).

The results of the survey on "current diagnostic methods used in patient management" are now avaible online.

Survey results

  • Saturday, 10 May 2014
    11.00 - 13.00 (Hall I)
    Educational Workshop 18: Human parasites of the gut: epidemiology and diagnostic approaches in the molecular era, organised jointly with the ESCMID Study Group for Clinical Parasitology (ESGCP).
    13.30 - 15.30 (Hall I)
    ESGMD Symposium: Application of new methods in medical microbiology and infection control, organised jointly with the ESCMID Study Group for Epidemiological Markers (ESGEM) and the ESCMID Study Group for Nosocomial Infections (ESGNI).
  • Sunday, 11 May 2014
    13.15 - 14.15 (Room 124)
    ESGMD Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
  • Tuesday, 13 May 2014
    7.45 - 8.45 (Hall D)
    ESGMD Meet-the-Expert Session: Management and troubleshooting of in-house molecular diagnostics in the microbiological lab.

As you know very well from your daily practice, the use of molecular methods for diagnosis and management of patients is commonplace in some areas and still in development in others.

 

Our aims with this survey are to

  • investigate the current use of molecular methods
  • estimate access to and usage of guidelines

Link to survey

Deadline for completion of the survey: 31 January 2014

Kate Templeton

for the ESGMD Executive Committee

  • Saturday, 27 April 2013
    11.00 - 13.00 (Hall C)
    ESGMD Educational Workshop 16: Molecular diagnosis for the top four infection-related acute hospital presentations: syndromic or sequential approach?
  • Sunday, 28 April 2013
    18.15 - 19.15 (Salon 20)
    ESGMD Business Meeting
    : All interested persons are cordially invited to join the meeting and plan future ESGMD activities.

For more details, please check the ECCMID programme.

ECCMID programme

  • 31 March, 11.00-13.00
    Educational Workshop EW19 "New developments in molecular diagnostics for intestinal parasites"
    Jointly arranged with ESGMD and ESGCP
  • 2 April, 13.00-14.00 (Meeting Room 7)
    ESGMD Business Meeting
    All interested persons are cordially invited to join the meeting and plan future ESGMD activities.

For more details, please check the ECCMID programme.

ECCMID programme

  • 7 May, 11.00-13.00
    Educational Workshop EW11 "Molecular Resistance Detection"
  • 9 May, 18.15-19.15 (Press Conference Room)
    ESGMD Business Meeting
    All interested persons are cordially invited to join the meeting and plan future ESGMD activities.

For more details, please check the ECCMID/ICC programme.

ECCMID/ICC programme

Ongoing Guideline Projects

  • Checklist for optimization and validation of real-time PCR assays. Raymaekers M, Smets R, Maes B, Cartuyvels R
    J Clin Lab Anal. 2009;23(3):145-51
  • Official partner for the German MDx Guidelines: Nukleinsäure-Amplifikationstechniken (NAT), Mikrobiologisch-infektiologische Qualitaetsstandards (MiQ, 1/2011, 3. Auflage)
  • Partner in the revision of updated MDx Guidelines in the Netherlands
  • Belgian MDx Guidelines: Reflections and proposals to assure quality in molecular diagnostics. Raymaekers M, Bakkus M, Boone E, de Rijke B, El Housni H, Descheemaeker P, De Schouwer P, Franke S, Hillen F, Nollet F, Soetens O,, Vankeerberghen A,, on behalf of MolecularDiagnostics.be
    Acta Clin Belg. 2011: 66 (1): 34-41
  • Participation in the International Working Group on the Standardisation of Genomic Amplification Techniques (SoGAT)

2009

  • Preparation of medical guidelines for standardization and basic requirements of molecular diagnostics of infectious diseases

2008

  • Participation with a poster in the European Network Corner during the 18th ECCMID Barcelona 2008 together with QCMD to inform on regular and pilot distributions of QCMD proficiency panels for assessing the quality of molecular methods for the diagnosis of infectious diseases.
  • Pilot programme on proficiency testing in collaboration with QCMD on the molecular detection of Bordetella pertussis. Scheduled for 2008.
  • Programme on proficiency testing in collaboration with QCMD on the molecular detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae. Scheduled for 2008.
Last update: 20 April 2016

Download the latest Annual Report.